Ask the Expert

Burden of Multiple Myeloma

Treatment resources

Clinical trials

Download the ClinTrial Refer App

Latest News

“Good-Risk” Group of Patients With Myeloma Saw Better Outcomes

This article was originally published by Cancer Therapy Advisor Researchers have used deep whole-genome sequencing (WGS) to identify genomic markers...
Continue Reading

Severe Renal Impairment Worsens Outcomes in Multiple Myeloma

This was originally published by AJMC Severe renal impairment (RI) is associated with decreased rates of survival among patients with multiple...
Continue Reading

Inpatient Mortality With Renal Impairment in Patients With Multiple Myeloma

This article was originally published by Cancer Therapy Advisor Receipt of dialysis may be a risk factor for inpatient mortality...
Continue Reading

EU Approval Urged for GSX’s Belantamab Mafodotin for Heavily Treated Myeloma

This post was originally published by Myeloma Research News GlaxoSmithKline’s investigational therapy belantamab mafodotin has been recommended for approved in the European...
Continue Reading

FDA Office Favors Antibody-drug Conjugate for Advanced Multiple Myeloma

An office of the U.S. Food and Drug Administration (FDA has recommended that belantamab mafodotin, GlaxoSmithKline’s investigational antibody-drug conjugate, be approved for...
Continue Reading

Upcoming Patient Seminar: Whangarei Myeloma Seminar

Come along to our Whangarei Myeloma Patient Seminar, hosted by Myeloma New Zealand and Leukaemia & Blood cancer New Zealand....
Continue Reading


Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.